The use of atomic force microscopy to study the conditioning of micronised budesonideJONES, Matthew D; YOUNG, Paul M; TRAINI, Daniela et al.International journal of pharmaceutics. 2008, Vol 357, Num 1-2, pp 314-317, issn 0378-5173, 4 p.Article

Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPDCAZZOLA, M; NOSCHESE, P; DE MICHELE, F et al.Respiratory medicine. 2006, Vol 100, Num 2, pp 212-217, issn 0954-6111, 6 p.Article

Preparation of budesonide/γ-cyclodextrin complexes in supercritical fluids with a novel SEDS methodTOROPAINEN, Tarja; VELAGA, Sitaram; HEIKKILÄ, Teemu et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 10, pp 2235-2245, issn 0022-3549, 11 p.Article

Les colites microscopiques = Microscopic colitisFOMEGNE, G; GRUSELLE, P.Revue médicale de Bruxelles. 2005, Vol 26, Num 1, pp 43-47, issn 0035-3639, 5 p.Article

In Vitro Delivery of Budesonide From 30 Jet Nebulizer/Compressor Combinations Using Infant and Child Breathing PatternsBERG, Elna B; PICARD, Robert J.Respiratory care. 2009, Vol 54, Num 12, pp 1671-1678, issn 0020-1324, 8 p.Article

Hypersensibilité au budésonide = Hypersensitivity to budesonideLE COZ, C.-J.Annales de dermatologie et de vénéréologie. 2002, Vol 129, Num 12, pp 1409-1410, issn 0151-9638, 2 p.Article

Chromatographic and mass spectral characterization of budesonide and a series of structurally related corticosteroids using LC-MSSHUGUANG HOU; HINDLE, Michael; BYRON, Peter R et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 1-2, pp 196-205, issn 0731-7085, 10 p.Article

In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspensionSMALDONE, G. C; CRUZ-RIVERA, M; NIKANDER, K et al.Journal of aerosol medicine. 1998, Vol 11, Num 2, pp 113-125, issn 0894-2684Article

Adjustable maintenance dosing with budesonide/formoterol or budesonide : Double-blind studyPOHL, W. R; VETTE, N; ZWICK, H et al.Respiratory medicine. 2006, Vol 100, Num 3, pp 551-560, issn 0954-6111, 10 p.Article

A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthmaSTÄLLBERG, B; EKSTRÖM, T; NEIJ, F et al.Respiratory medicine. 2008, Vol 102, Num 10, pp 1360-1370, issn 0954-6111, 11 p.Article

Azo-reductase activated budesodine prodrugs for colon targetingMARQUEZ RUIZ, Juan F; KEDZIORA, King; O'REILLY, Mary et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 24, pp 7573-7577, issn 0960-894X, 5 p.Article

Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophagesDONNELLY, L. E; TUDHOPE, S. J; FENWICK, P. S et al.The European respiratory journal. 2010, Vol 36, Num 1, pp 178-186, issn 0903-1936, 9 p.Article

Evidence of the in vivo esterification of budesonide in human airwaysMAASSEN VAN DEN BRINK, Karen I; BOORSMA, Martin; STAAL-VAN DEN BREKEL, A. Jeske et al.British journal of clinical pharmacology. 2008, Vol 66, Num 1, pp 27-35, issn 0306-5251, 9 p.Article

Neuroendocrine cells of nasal mucosa are a cellular source of brain-derived neurotrophic factorJORNOT, L; LACROIX, J. S; ROCHAT, T et al.The European respiratory journal. 2008, Vol 32, Num 3, pp 769-774, issn 0903-1936, 6 p.Article

The Influence of Crystal Habit on the Prediction of Dry Powder Inhalation Formulation Performance Using the Cohesive-Adhesive Force Balance ApproachHOOTON, Jennifer C; JONES, Matthew D; HARRIS, Haggis et al.Drug development and industrial pharmacy. 2008, Vol 34, Num 9, pp 974-983, issn 0363-9045, 10 p.Article

Evaluation of efficacy of topical corticosteroid for the clinical treatment of nasal polyposis : searching for clinical events that may predict response to treatmentVALERA, Fabiana C. P; ANSELMO-LIMA, Wilma T.Rhinology. 2007, Vol 45, Num 1, pp 59-62, issn 0300-0729, 4 p.Article

High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort TurbuhalerASSI, K. H; TARSIN, W; CHRYSTYN, H et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 1, pp 325-328, issn 0731-7085, 4 p.Article

The effect of inhaled budesonide on adrenal and growth suppression in asthmatic childrenPRIFTIS, K. N; PAPADIMITRIOU, A; GATSOPOULOU, E et al.The European respiratory journal. 2006, Vol 27, Num 2, pp 316-320, issn 0903-1936, 5 p.Article

Budesonide offers no advantage when added to oral dexamethasone in the treatment of croupGEELHOED, Gary Cornelis.Pediatric emergency care. 2005, Vol 21, Num 6, pp 359-362, issn 0749-5161, 4 p.Article

Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localizationHERFARTH, H; GROSS, V; ANDUS, T et al.International journal of colorectal disease (Print). 2004, Vol 19, Num 2, pp 147-152, issn 0179-1958, 6 p.Article

Comparison of two budesonide dry powder inhalers in the treatment of asthma in childrenVANTO, T; HÄMÄLÄINEN, K. M; VAHTERISTO, M et al.Journal of aerosol medicine. 2004, Vol 17, Num 1, pp 15-24, issn 0894-2684, 10 p.Article

Once-daily budesonide aqueous nasal spray for allergic rhinitis: A reviewSTANALAND, Brett E.Clinical therapeutics. 2004, Vol 26, Num 4, pp 473-492, issn 0149-2918, 20 p.Article

Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler®) during 52 weeks of treatment in adults and children with persistent asthmaTINKELMAN, David G; BRONSKY, Edwin A; GROSS, Gary et al.The Journal of asthma. 2003, Vol 40, Num 3, pp 225-236, issn 0277-0903, 12 p.Article

Budesonide Use in Pediatric Crohn DiseaseOTLEY, Anthony; LELEIKO, Neal; OLIVA-HEMKER, Maria et al.Journal of pediatric gastroenterology and nutrition. 2012, Vol 55, Num 2, pp 200-204, issn 0277-2116, 5 p.Article

Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot studyWAGNER, Michael; PETERSON, ChristeRG B; STOLT, Ingrid et al.Scandinavian journal of gastroenterology. 2011, Vol 46, Num 7-8, pp 849-854, issn 0036-5521, 6 p.Article